OKLAHOMA CITY (Jan. 4, 2024) –Attorney General Gentner Drummond announced today he is exploring potential legal action against insulin manufacturers and pharmacy benefit managers for wrongful conduct that resulted in artificially increased prices for insulin.
Drummond has issued a Request for Proposal (RFP) for outside counsel to investigate conduct and potentially pursue litigation.